The American Diabetes Association (ADA) recommends it as a first-line therapy for type 2 diabetes patients at high risk of cardiovascular disease, and it is already widely prescribed for metabolic dysfunction-associated steatohepatitis (MASH) and chronic kidney disease, as well as blood glucose and obesity management
This makes the recent launch of Mounjaro (Tirzepatide) by EliLilly in India, the first major weightloss and diabetes drug of its kind to enter the country an important milestone
There is no evidence to suggest that the fundamental mechanisms of action differ between sexes
Follow-ups on a monthly basis were conducted for two years after treatment to confirm the regimens effectiveness, and no new lesions were reported for at least six months after the initial three-year treatment regimen
Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex
Lilly continues to study the long-term effects of these medicines and works closely with healthcare professionals and people living with obesity to support their safe and appropriate use." What Happens Next The study's authors recommend that guidelines be reviewed so that patients receiving the medications are made aware of the likelihood of rapid weight regain unless the medication is sustained long-term